Piracetam: a review of pharmacological properties and clinical uses.

  title={Piracetam: a review of pharmacological properties and clinical uses.},
  author={Bengt Winblad},
  journal={CNS drug reviews},
  volume={11 2},
  • B. Winblad
  • Published 7 June 2006
  • Medicine, Psychology
  • CNS drug reviews
Piracetam, a derivative of the neurotransmitter gamma-aminobutyric acid (GABA), has a variety of physiological effects that may result, at least in part, from the restoration of cell membrane fluidity. At a neuronal level, piracetam modulates neurotransmission in a range of transmitter systems (including cholinergic and glutamatergic), has neuroprotective and anticonvulsant properties, and improves neuroplasticity. At a vascular level, it appears to reduce erythrocyte adhesion to vascular… 

Figures and Tables from this paper

Recent Advances on Piracetam

Piracetam modifies neurotransmission in a range of transmitter systems, has neuroprotective and anticonvulsant properties and improves neuroplasticity, and appears to reduce erythrocyte adhesion to vascular endothelium, hinder vasospasm and facilitate microcirculation.

A Review on Synthesis and Pharmacological Activities of Piracetam and its Derivatives

Piracetam is generally utilized as a nootropic drug, which is normally used in the treatment of CNS disorders. Piracetam is a cyclic compound and a derivative of γ-aminobutyric acid and improves

Heroin–piracetam mixture: Suggested mechanisms of action and risks of misinterpretation for drug users

The relevant literature is reviewed and the main hypothetical mechanisms that justify its use as a heroin adulterant are suggested, to understand if its use could help people who want to come off heroin by reducing withdrawal symptoms and to give useful information that permit us to understand why drug trafficking organisations started to use piracetam.

L-carnitine+piracetam for fatigue and muscular strength of patients with post-poliomyelitis

Recent researches evaluating the action of the fixed dose combination of L-carnitine with Piracetam have shown that when associated, they present synergic and complementary action protecting mitochondrial dysfunction.

The issues of classification and characterization of neurotropic agents in the treatment of patients with cerebrovascular diseases

It is suggested that taking into account the predominant mechanism of action targeting for a pathological process, neurotropic agents should be divided into 4 groups such as neuroprotectors, neurometabolics, nootropics and neurotrophic agents (direct activators of neutrophin synthesis in the brain).

Dissociative Symptoms Secondary to Piracetam: A Case Report

A case is reported with the diagnosis of peripheral vertigo where piracetam was used as pari of combination therapy and dissociative symptom; like depersonalization and derealization occurred after use and these symptoms disappeared after discontinuation of Piracetam.

Novel psychoactive substances of interest for psychiatry

Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives, psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives, phencyclidine‐like

Analgesic activity of piracetam: Effect on cytokine production and oxidative stress

A novel CaV2.2 channel inhibition by piracetam in peripheral and central neurons

Evidence is provided of piracetam's actions on CaV2.2 channels in peripheral neurons, which might explain some of its nootropic effects in central neurons.



Piracetam: novelty in a unique mode of action.

This novel mechanism of piracetam combines a rather non-specific physico-chemical mode of action with the pharmacological and clinical experience with this unique drug - effects are always much more pronounced when function is impaired.

Synergistic effects of oxiracetam and piracetam in combination with antiepileptic drugs *

The present study was designed to show to what extent the nootropic agents piracetam and oxiracetam might affect the anticonvulsant action of carbamazepine, phenytoin, phenobarbitone, clonazepam and valproinate sodium.

Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects.

The random administration of four different single oral doses of piracetam has confirmed and explicited its platelet anti-aggregant and rheological properties and confirmed the presence of four sites of action: the vessel wall, platelets, plasma and cell membranes (RBC, WBC), which provide the basis for the potentially important antithrombotic activity of Piracetam.

Piracetam potentiates the antiepileptic action of carbamazepine in chronic experimental limbic epilepsy

In this model, carbamazepine can reduce the severity of the epilepsy and at the same time reduce any memory deficit resulting from the epilepsy, while phenytoin is not a particularly effective anticonvulsant.

Piracetam in the treatment of acute stroke.

The Piracetam in Acute Stroke Study was performed and the chief results have recently been reported, with a significant increase compared with placebo in the number of patients recovered from aphasia but no significant neurologic or functional improvement.

The effects of piracetam on lipofuscin of the rat cerebellar and hippocampal neurons after long-term alcohol treatment and withdrawal: a quantitative study.

Piracetam was found to markedly decrease the formation of neuronal lipofuscin in alcohol-treated and withdrawn rats, which might be related either to a protective effect on the intraneuronal membranous system or to an antioxidant property of this molecule.

Pyrrolidone derivatives

Potentiation of the anticonvulsant effects of antiepileptic drugs by “nootropics”; a potential new therapeutic approach

A large series of experiments on rats were carried out with the aim of investigating the combined effects of nootropics and antiepileptics on convulsions induced by electroshock, and finding that both piracetam and vincamine potentiated the anticonvulsant effects of carbamazepine.

[Therapeutic effect of piracetam in a case of posthypoxic action myoclonus (author's transl)].

The fortuitous discovery of the effectively curative action of piracetam doubly valuable is made.